Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

staging

  • Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
    Open Access
    Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
    Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
    Journal of Nuclear Medicine September 7, 2023, jnumed.123.266046; DOI: https://doi.org/10.2967/jnumed.123.266046
  • Staging Prostate Cancer with <sup>68</sup>Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
    Open Access
    Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
    Mikhail Kesler, Dan Cohen, Charles Levine, David Sarid, Daniel Keizman, Ofer Yossepowitch and Einat Even-Sapir
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1030-1035; DOI: https://doi.org/10.2967/jnumed.122.265371
  • You have access
    18F-FDG PET/CT in the Management of Osteosarcoma
    Chiwoo Oh, Michael W. Bishop, Steve Y. Cho, Hyung-Jun Im and Barry L. Shulkin
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 842-851; DOI: https://doi.org/10.2967/jnumed.123.265592
  • Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    You have access
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Katharina Lueckerath, Stefan Kasper, Michael Nader, Hans-Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann and Wolfgang P. Fendler
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 711-716; DOI: https://doi.org/10.2967/jnumed.122.264689
  • <sup>18</sup>F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
    You have access
    18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
    Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb and Alessio Imperiale
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1865-1870; DOI: https://doi.org/10.2967/jnumed.122.263984
  • You have access
    18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial
    Rathan M. Subramaniam, Fenghai M. Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M. Intenzo, Lilja Solnes, JoRean Sicks, Brendan C. Stack and Val J. Lowe
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1887-1890; DOI: https://doi.org/10.2967/jnumed.122.263902
  • Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
    You have access
    Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
    Marinus J. Hagens, Daniela E. Oprea-Lager, André N. Vis, Maurits Wondergem, Maarten L. Donswijk, Dennie Meijer, Louise Emmett, Pim J. van Leeuwen and Henk G. van der Poel
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1531-1536; DOI: https://doi.org/10.2967/jnumed.121.263139
  • In Vivo <sup>18</sup>F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy
    Open Access
    In Vivo 18F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy
    Maura Malpetti, Sanne S. Kaalund, Kamen A. Tsvetanov, Timothy Rittman, Mayen Briggs, Kieren S.J. Allinson, Luca Passamonti, Negin Holland, P. Simon Jones, Tim D. Fryer, Young T. Hong, Antonina Kouli, W. Richard Bevan-Jones, Elijah Mak, George Savulich, Maria Grazia Spillantini, Franklin I. Aigbirhio, Caroline H. Williams-Gray, John T. O’Brien and James B. Rowe
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1052-1057; DOI: https://doi.org/10.2967/jnumed.121.262985
  • Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
    You have access
    Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
    Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398
  • PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma
    You have access
    PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma
    Andrea C. Lo, Lyndon P. James, Anca Prica, Adam Raymakers, Stuart Peacock, Melody Qu, Alex V. Louie, Kerry J. Savage, Laurie H. Sehn, David Hodgson, Joanna C. Yang, Hans T.T. Eich, Andrew Wirth and M.G. Myriam Hunink
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 543-548; DOI: https://doi.org/10.2967/jnumed.121.262324

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire